Huh7 Xenografts

 

 

Rincon Bio performs Huh7 xenograft models to test efficacy of preclinical therapies.  Please see below for additional information or to request a quote. 

Liver

Huh7 cells were derived from a 57 year old Japanese male with hepatocellular carcinoma

Notes

Oncogene: p53 mutation

in vivo

Used in xenografts to test the efficacy of novel cancer therapeutics.  Tumors develop after being injected into the flank of immunocompromised mice. 

Request Quote

Receive a quote within one business day for a Huh7 Xenograft

Rincon Bio Growth Curve

huh7.png

Cell Line: Huh-7

Mouse Strain: NOD.CB17 Prkd<Scid>/NCrHsd from Envigo

Gender: Male

Positive Control: Sorafenib and Ozanimod

Concentration: Sorafenib 30mg/kg, Ozanimod 60mg/kg

Matrigel: Yes

Cells Implanted per Animal: 3 million

From implant to stratification: 32 days

Stratification Size: 115mm^3

Dosing: Daily oral dosing for 28 days

WHY WORK WITH

RINCON BIO?

DOMESTIC QUALITY at COMPETITIVE PRICES

 

When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices

SPEED TO INITIATION
 

Most efficacy studies can be initiated within two business days.

PERSONAL TOUCH

 

We love our clients!  We are flexible and easy to work with.  And we take a personal interest in our clients' studies.